121 related articles for article (PubMed ID: 4005848)
1. S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level.
Smets LA; Homan-Blok J
Cancer Res; 1985 Jul; 45(7):3113-7. PubMed ID: 4005848
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H
Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533
[TBL] [Abstract][Full Text] [Related]
3. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor.
Fietkau R; Friede H; Maurer-Schultze B
Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of dexamethasone restricted to noncycling, early G1-phase cells of L1210 leukemia.
Smets LA; Bout B; Brouwer M; Tulp A
J Cell Physiol; 1983 Sep; 116(3):397-403. PubMed ID: 6885934
[TBL] [Abstract][Full Text] [Related]
5. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
Raymakers RA; Slocum HK; Minderman H; Malmberg M; Rustum YM
Exp Hematol; 1993 May; 21(5):602-7. PubMed ID: 8513859
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
Chou TC; Hutchinson DJ; Schmid FA; Philips FS
Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
[TBL] [Abstract][Full Text] [Related]
7. Flow microfluorometric analysis of the cell cycle phase cytotoxicity of ARA-C.
Hromas RA; Markel DE; Scholes VE
Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):365-8. PubMed ID: 7444164
[TBL] [Abstract][Full Text] [Related]
8. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
Colly LP; Peters WG; Willemze R
Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691
[TBL] [Abstract][Full Text] [Related]
9. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
Pallavicini MG; Gray JW; Folstad LJ
Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956
[TBL] [Abstract][Full Text] [Related]
11. Flow microfluorimetric analysis of sensitive and resistant leukemia L1210 following 1-beta-D-arabinofuranosylcytosine in vivo.
Alabaster O; Bunnag B
Cancer Res; 1976 Aug; 36(8):2744-9. PubMed ID: 1277184
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
Minford J; Kerrigan D; Nichols M; Shackney S; Zwelling LA
Cancer Res; 1984 Dec; 44(12 Pt 1):5583-93. PubMed ID: 6208999
[TBL] [Abstract][Full Text] [Related]
14. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
Moran RE; Straus MJ
Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
[TBL] [Abstract][Full Text] [Related]
15. Regulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in human leukemia cells by deoxycytidine 5'-triphosphate.
Liliemark JO; Plunkett W
Cancer Res; 1986 Mar; 46(3):1079-83. PubMed ID: 3484676
[TBL] [Abstract][Full Text] [Related]
16. Effect of tetrahydrouridine on the action of 1-beta-D-arabinofuranosylcytosine in synchronized cultures of normal rat kidney cells.
Wan CW; Mak TW
Cancer Res; 1979 Oct; 39(10):3981-5. PubMed ID: 476637
[TBL] [Abstract][Full Text] [Related]
17. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
[TBL] [Abstract][Full Text] [Related]
18. Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinations.
Bhuyan BK; Blowers CL; Neil GL; Bono VH; Day KJ
Cancer Res; 1977 Sep; 37(9):3204-8. PubMed ID: 560250
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
Bhuyan BK; Fraser TJ; Day KJ
Cancer Res; 1977 Apr; 37(4):1057-63. PubMed ID: 139202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]